Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.38 - $54.59 $2.65 Million - $3.34 Million
61,200 Added 582.86%
71,700 $3.76 Million
Q2 2024

Aug 14, 2024

SELL
$51.76 - $64.15 $1.53 Million - $1.9 Million
-29,600 Reduced 73.82%
10,500 $575,000
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $1.95 Million - $2.29 Million
40,100 New
40,100 $2.24 Million
Q2 2023

Aug 14, 2023

SELL
$42.28 - $51.43 $1.53 Million - $1.86 Million
-36,200 Reduced 78.35%
10,000 $514,000
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $1.89 Million - $2.69 Million
46,200 New
46,200 $2.01 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $856,149 - $1.18 Million
17,700 Added 272.31%
24,200 $1.23 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.